Genetic variation and statistical considerations in relation to overfeeding and underfeeding in humans

Nutrition

Volumn 20, Issue 1, 2004, Pages 145-154

  St Pierre, David H ^b   George, Varghese ^b   Rabasa Lhoret, Rémi ^b   Poehlman, Eric T ^a  

^a Unite Metabolique   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); APOLIPOPROTEIN B; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; GLUCOCORTICOID RECEPTOR; LEPTIN RECEPTOR; LIPOPROTEIN LIPASE; UNCOUPLING PROTEIN;

BODY COMPOSITION; CORRELATION ANALYSIS; DATA ANALYSIS; ENERGY METABOLISM; ENZYME ACTIVITY; GENE FREQUENCY; GENE INTERACTION; GENE LOCATION; GENE STRUCTURE; GENETIC VARIABILITY; GENOMICS; HUMAN; INFORMATION PROCESSING; INSULIN SENSITIVITY; INTRON; LINE DIFFERENCE; MALNUTRITION; NUTRITION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVERNUTRITION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL PARAMETERS;

EID: 0347753798     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2003.09.025     Document Type: Article

References (137)

1. Kopelman P.G. Obesity as a medical problem. Nature. 404:2000;634.
2. Wadden T.A. The treatment of obesity an overview . Stunkard A.J., Wadden T.A. Obesity: theory and therapy. 1993;197 Raven Press, New York.
3. Wadden T.A. treatment of obesity by moderate and several caloric restriction results of clinical research trials . Ann Intern Med. 119:1993;688.
4. Pérusse L., Bouchard C. Gene-diet interactions in obesity. Am J Clin Nutr. 72:2000;1285S.
5. Rabasa-Lhoret R, Laville M. Physiopathologie des obésités et du diabète type 2. In: Encyclopédie médico chirurgicale glandes, endocrinologie et nutrition. Paris: Éditions scientifiques et médicales Elservier, 2003:10-506-F6.
6. De Pergola G., Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest. 25:2002;899.
7. Rosmond R. The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res. 10:2002;1078.
8. van Baak M.A. The peripheral sympathetic nervous system in human obesity. Obes Rev. 2:2001;3.
9. Stumvoll M., Haring H. Insulin resistance and insulin sensitizers. Horm Res. 55:2001;3.
10. Arner P. Obesity - a genetic disease of adipose tissue? Br J Nutr. 83:2000;S9.
11. Barsh G.S., Farooqi I.S., O'Rahilly S. Genetics of body-weight regulation. Nature. 404:2000;644.
12. Arner P., Hoffstedt J. Adrenoceptor genes in human obesity. Adrenoceptor genes in human obesity. J Intern Med. 245:1999;667.
13. Maes H.H., Neale M.C., Eaves L.J. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 27:1997;325.
14. Ferrell R.E. Obesity choosing genetic approaches from a mixed menu . Hum Biol. 65:1993;967.
15. Sims E.A., Goldman R.F., Gluck C.M., Horton E.S., Kelleher P.C., Rowe D.W. Experimental obesity in man. Trans Assoc Am Phys. 81:1968;153.
16. Poehlman E.T., Tremblay A., Després J.P., et al. Genotype-controlled changes in body composition and fat morphology following overfeeding in twins. Am J Clin Nutr. 43:1986;723.
17. Poehlman E.T., Després J.P., Marcotte M., Tremblay A., Theriault G., Bouchard C. Genotype dependency of adaptation in adipose tissue metabolism after short-term overfeeding. Am J Physiol. 250:1986;E480.
18. Poehlman E.T., Tremblay A., Fontaine E., et al. Genotype dependency of the thermic effect of a meal and associated hormonal changes following short-term overfeeding. Metabolism. 35:1986;30.
19. Després J.P., Poehlman E.T., Tremblay A., et al. Genotype-influenced changes in serum HDL cholesterol after short-term overfeeding in man association with plasma insulin and triglyceride levels . Metabolism. 36:1987;363.
20. Bouchard C., Tremblay A., Després J.P., et al. The response to long-term overfeeding in identical twins. N Engl J Med. 322:1990;1477.
21. Caron M.G., Lefkowitz R.J. Catecholamine receptors. Rec Prog Horm Res. 48:1993;277.
22. Emorine L.J., Marullo S., Briend M.M., et al. Molecular characterization of the human β3-adrenergic receptor. Science. 245:1989;1118.
23. Zaagsma J., Nahorski S.R. Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical β-adrenoreceptor? Trends Pharmacol Sci. 11:1990;3.
24. Granneman J., Lahners K., Chaudhry A. Characterization of the human β3-adrenergic receptor gene. Mol Pharmacol. 44:1993;264.
25. Kobilka B.K., Dixon R.A., Frielle T., et al. cDNA for the human beta 2-adrenergic receptor a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor . Proc Natl Acad Sci USA. 84:1987;46.
26. Büscher R., Herrmann V., Insel P.A. PCR-based methods for identifying genetic variations in human alpha1B- and beta2-adrenergic receptors. Mol Genet Metab. 64:1998;266.
27. Large V., Hellstrom L., Reynisdottir S., et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest. 100:1997;3005.
28. Oppert J.M., Vohl M.C., Chagnon M., et al. DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. Int J Obes Relat Metab Disord. 18:1994;526.
29. Ishiyama-Shigemoto S., Yamada K., Yuan X., Ichikawa F., Nonaka K. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 42:1999;98.
30. Echwald S.M., Sorensen T.I., Tybjaerg-Hansen A., Andersen T., Pedersen O. Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men. Diabetes. 47:1998;1657.
31. Hellstrom L., Large V., Reynisdottir S., Wahrenberg H., Arner P. The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med. 245:1999;253.
32. Meirhaeghe A., Helbecque N., Cottel D., Amouyel P. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet. 353:1999;896.
33. Ukkola O., Tremblay A., Sun G., Chagnon Y.C., Bouchard C. Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding. Eur J Clin Nutr. 55:2001;1008.
34. Goldberg I.J., Le N.A., Ginsberg H.N., Krauss R.M., Lindgren F.T. Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey. J Clin Invest. 81:1988;561.
35. Sparkes R.S., Zollman S., Klisak I. Human genes involved in lipolysis of plasma lipoproteins mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21 . Genomics. 1:1987;138.
36. Oka K., Tkalcevic G.T., Nakano T., Tucker H., Ishimura-Oka K., Brown W.V. Structure and polymorphic map of human lipoprotein lipase gene. Biochim Biophys Acta. 1049:1990;21.
37. Wion K.L., Kirchgessner T.G., Lusis A.J., Schotz M.C., Lawn R.M. Human lipoprotein lipase complementary DNA sequence. Science. 235:1987;1638.
38. Borensztajn J. Lipoprotein lipase. In: Borensztajn J, ed. Lipoprotein lipase. Chicago: Evener, 1987:133.
39. Murthy V., Julien P., Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther. 70:1996;101.
40. Ukkola O., Tremblay A., Bouchard C. Lipoprotein lipase polymorphisms and responses to long-term overfeeding. J Intern Med. 251:2002;429.
41. Gotoda T., Yamada N., Murase T., et al. Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion. J Lipid Res. 33:1992;1067.
42. Heinzmann C., Ladias J., Antonarakis S., Kirchgessner T., Schotz M., Lusis A.J. RFLP for the human lipoprotein lipase (LPL) gene Hind III . Nucleic Acids Res. 15:1987;6763.
43. Jemaa R., Tuzet S., Portos C., Betoulle D., Apfelbaum M., Fumeron F. Lipoprotein lipase gene polymorphisms associations with hypertriglyceridemia and body mass index in obese people . Int J Obes Relat Metab Disord. 19:1995;270.
44. Taskinen M.R., Nikkila E.A. High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man-evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. Clin Chim Acta. 112:1981;325.
45. Laakso M., Pyorala K. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes. Metabolism. 39:1990;117.
46. Tilly-Kiesi M., Knudsen P., Groop L., Taskinen M.R. Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group. J Lipid Res. 37:1996;1569.
47. Stocks J., Thorn J.A., Galton D.J. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res. 33:1992;853.
48. Garenc C., Perusse L., Gagnon J., et al. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations the HERITAGE Family Study . Metabolism. 49:2000;432.
49. Fisher K.L., FitzGerald G.A., Lawn R.M. Two polymorphisms in the human lipoprotein lipase (LPL) gene. Nucleic Acids Res. 15:1987;7657.
50. Li S.R., Oka K., Galton D., Stocks J. Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Res. 16:1988;2358.
51. Wang X.L., McCredie R.M., Wilcken D.E. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation. 93:1996;1339.
52. Hill J.O., Wyatt H.R., Reed G.W., Peters J.C. Obesity and the environment where do we go from here? Science. 299:2003;853.
53. Harnack L.J., Jeffery R.W., Boutelle K.N. Temporal trends in energy intake in the United States an ecologic perspective . Am J Clin Nutr. 71:2000;1478.
54. Fagot-Campagna A., Knowler W.C., Narayan K.M., Hanson R.L., Saaddine J., Howard B.V. HDL cholesterol subfractions and risk of developing type 2 diabetes among Pima Indians. Diabetes Care. 22:1999;271.
55. Yu S., Yarnell J.W., Sweetnam P., Bolton C.H. High density lipoprotein subfractions and the risk of coronary heart disease 9-years follow-up in the Caerphilly Study . Atherosclerosis. 166:2003;331.
56. Ricquier D., Fleury C., Larose M., et al. Contributions of studies on uncoupling proteins to research on metabolic diseases. J Intern Med. 245:1999;637.
57. Klingenberg M., Huang S.G. Structure and function of the uncoupling protein from brown adipose tissue. Biochim Biophys Acta. 1415:1999;271.
58. Cassard-Doulcier A.M., Bouillaud F., Mattei M.G., et al. Human uncoupling protein gene structure, comparison with rat gene, and assignment to the long arm of chromosome 4 . J Cell Biochem. 43:1990;255.
59. Fogelholm M., Valve R., Kukkonen-Harjula K., et al. Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women. J Clin Endocrinol Metab. 83:1998;4246.
60. Cassard-Doulcier A.M., Bouillaud F., Chagnon M., et al. The Bcl I polymorphism of the human uncoupling protein (ucp) gene is due to a point mutation in the 5′-flanking region. Int J Obes Relat Metab Disord. 20:1996;278.
61. Clément K., Ruiz J., Cassard-Doulcier A.M., et al. Additive effect of A→G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord. 20:1996;1062.
62. Fumeron F., Durack-Bown I., Betoulle D., et al. Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord. 20:1996;1051.
63. Warden C. Genetics of uncoupling proteins in humans. Int J Obes Relat Metab Disord. 23:1999;S46.
64. Hu X., Murphy F., Karwautz A., et al. Analysis of microsatellite markers at the UCP2/UCP3 locus on chromosome 11q13 in anorexia nervosa. Mol Psychiatry. 7:2002;276.
65. Fleury C., Neverova M., Collins S., et al. Uncoupling protein-2 a novel gene linked to obesity and hyperinsulinemia . Nat Genet. 15:1997;269.
66. Gimeno R.E., Dembski M., Weng X., et al. Cloning and characterization of an uncoupling protein homolog a potential molecular mediator of human thermogenesis . Diabetes. 46:1997;900.
67. Boss O., Samec S., Paoloni-Giacobino A., et al. Uncoupling protein-3 a new member of the mitochondrial carrier family with tissue-specific expression . FEBS Lett. 408:1997;39.
68. Vidal-Puig A., Solanes G., Grujic D., Flier J.S., Lowell B.B. UCP3 an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue . Biochem Biophys Res Commun. 235:1997;79.
69. Sesti G., Cardellini M., Marini M.A., et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes. 52:2003;1280.
70. Bouchard C., Perusse L., Chagnon Y.C., Warden C., Ricquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet. 6:1997;1887.
71. + pump. Clin Sci (Lond). 95:1998;3.
72. Lingrel J.B., Young R.M., Shull M.M. Multiple forms of the Na,K-ATPase their genes and tissue specific expression . Prog Clin Biol Res. 268B:1988;105.
73. Swaminathan R., Burrows G., McMurray J. Energy cost of sodium pump activity in man an in vivo study of metabolic rate in human subjects given dioxin . IRCS Med Sci. 10:1982;949.
74. James J.H., Wagner K.R., King J.K., et al. Stimulation of both aerobic glycolysis and Na(+)-K(+)-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol. 277:1999;E176.
75. Katzmarzyk P.T., Rankinen T., Perusse L., et al. Linkage and association of the sodium potassium-adenosine triphosphatase alpha2 and beta1 genes with respiratory quotient and resting metabolic rate in the Quebec Family Study. J Clin Endocrinol Metab. 84:1999;2093.
76. +-ATPase alpha 2-gene, and skeletal muscle characteristics in response to long-term overfeeding. J Appl Physiol. 94:2003;1870.
77. Rosmond R., Dallman M.F., Bjorntorp P. Stress-related cortisol secretion in men relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities . J Clin Endocrinol Metab. 83:1998;1853.
78. Bjorntorp P., Holm G., Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabetes Med. 16:1999;373.
79. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 12:1991;118.
80. Rosmond R., Bjorntorp P. Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity. Metabolism. 47:1998;1187.
81. Bouchard C., Pérusse L., Rice T., Rao D.C. The genetics of human obesity. Bray G.A., Bouchard C., James W.P.T. Handbook of obesity. 1998;157 Marcel Dekker, New York.
82. Rosmond R., Chagnon Y.C., Holm G., et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res. 8:2000;211.
83. Weaver J.U., Hitman G.A., Kopelman P.G. An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol. 9:1992;295.
84. Buemann B., Vohl M.C., Chagnon M., et al. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res. 5:1997;186.
85. Ukkola O., Rosmond R., Tremblay A., Bouchard C. Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis. 157:2001;221.
86. Zhang H., Reymer P.W., Liu M.S., et al. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291→Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol. 15:1995;1695.
87. Tartaglia L.A., Dembski M., Weng X., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1995;1263.
88. Thompson D.B., Ravussin E., Bennett P.H., Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet. 6:1997;675.
89. Chagnon Y.C., Chung W.K., Perusse L., Chagnon M., Leibel R.L., Bouchard C. Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes Relat Metab Disord. 23:1999;278.
90. Ukkola O., Tremblay A., Després J.P., Chagnon Y.C., Campfield L.A., Bouchard C. Leptin receptor Gln223Arg variant is associated with a cluster of metabolic abnormalities in response to long-term overfeeding. J Intern Med. 248:2000;435.
91. Connacher A.A., Bennet W.M., Jung R.T. Clinical studies with the β-adrenoreceptor agonist BRL 26830A. Am J Clin Nutr. 55:1992;258S.
92. 2-adrenergic receptor how structure elucidates function . Annu Rev Pharmacol Toxicol. 32:1992;167.
93. 3-adrenergic-receptor genes. Eur J Biochem. 213:1993;1117.
94. 3-adrenergic receptor gene. N Engl J Med. 333:1990;343.
95. Sung C.H., Davenport C.M., Nathans J. Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. J Biol Chem. 268:1993;2664.
96. Yoshida T., Sakane N., Umekawa T., Kogure A., Takakura Y., Kondo M. Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet. 346:1995;1433.
97. Sakane N., Yoshida T., Umekawa T., Kogure A., Takakura Y., Kondo M. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care. 20:1997;1887.
98. Rawson E.S., Nolan A., Silver K., Shuldiner A.R., Poehlman E.T. No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, Caucasian postmenopausal women. Metabolism. 51:2002;801.
99. Tchernof A., Starling R.D., Turner A., et al. Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes. 49:2000;1709.
100. Kee F., Young I.S., Poirier O., et al. Do polymorphisms of apoB, LPL or apoE affect the hypocholesterolemic response to weight loss? Atherosclerosis. 153:2000;119.
101. Jemaa R., Tuzet S., Betoulle D., Apfelbaum M., Fumeron F. Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int J Obes Relat Metab Disord. 21:1997;280.
102. Danielsson B., Ekman R., Johansson B.G., Nilsson-Ehle P., Petersson B.G. Isolation of a high density lipoprotein with high contents of arginine-rich apoprotein (apoE) from rat plasma. FEBS Lett. 86:1978;299.
103. Ordovas J.M., Schaefer E.J. Genetic determinants of plasma lipid response to dietary intervention the role of the APOA1/C3/A4 gene cluster and the APOE gene . Br J Nutr. 83:2000;S127.
104. Vincent S., Planells R., Defoort C., et al. Genetic polymorphisms and lipoprotein responses to diets. Proc Nutr Soc. 61:2002;427.
105. Mahley R.W. Apolipoprotein E cholesterol transport protein with expanding role in cell biology . Science. 240:1988;622.
106. Beisiegel U., Weber W., Ihrke G., Herz J., Stanley K.K. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341:1989;162.
107. Eichner J.E., Dunn S.T., Perveen G., Thompson D.M., Stewart K.E., Stroehla B.C. Apolipoprotein E polymorphism and cardiovascular disease a HuGE review . Am J Epidemiol. 155:2002;487.
108. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1.
109. Ordovas J.M., Litwack-Klein L., Wilson P.W., Schaefer M.M., Schaefer E.J. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res. 28:1987;371.
110. Schaefer E.J., Lamon-Fava S., Johnson S., et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb. 14:1994;1105.
111. Muls E., Kempen K., Vansant G., Cobbaert C., Saris W. The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-I and B, and lipoprotein(a). Int J Obes Relat Metab Disord. 17:1993;711.
112. Young S.G. Recent progress in understanding apolipoprotein B. Circulation. 82:1990;1574.
113. Weston J.E., Moreel J.F.R., McMaster D., et al. An association of body mass index with myocardial infraction in individuals with a polymorphism of the apoB gene. Ir J Med Sci. 162:1993;30.
114. Harper M.E., Dent R., Monemdjou S., et al. Decreased mitochondrial proton leak and reduced expression of uncoupling protein 3 in skeletal muscle of obese diet-resistant women. Diabetes. 51:2002;2459.
115. Clapham J.C., Arch J.R., Chapman H., et al. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature. 406:2000;415.
116. Argyropoulos G., Brown A.M., Willi S.M., et al. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest. 102:1998;1345.
117. Chung W.K., Luke A., Cooper R.S., et al. Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. Diabetes. 48:1999;1890.
118. Nevin D.N., Zambon A., Furlong C.E., et al. Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler Thromb Vasc Biol. 16:1996;1243.
119. Hegele R.A. Paraoxonase genes and disease. Ann Med. 31:1999;217.
120. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet. 3:1993;73.
121. Kuremoto K., Watanabe Y., Ohmura H., Shimada K., Mokuno H., Daida H. R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. J Atheroscler Thromb. 10:2003;85.
122. Obata T., Ito T., Yonemura A., Ayaori M., Nakamura H., Ohsuzu F. R192Q paraoxonase gene variant is associated with a change in HDL-cholesterol level during dietary caloric restriction in nondiabetic healthy males. J Atheroscler Thromb. 10:2003;57.
123. Roethlisberger F.J., Dickson W.J., Wright H.A. Management and the worker. 1946;Harvard University Press, Cambridge.
124. Probstfield J.L., Russell M.L., Henske J.C., Reardon R.J., Insull W. Successful program for recovery of dropouts to a clinical trial. Am J Med. 80:1986;777.
125. Pocock S.J. Clinical trials a practical approach . 1983;John Wiley & Sons, New York.
126. Kleinbaum D.G., Kupper L.L., Muller K.E., Nizam A. Applied regression analysis and other multivariate methods. 1998;Duxbury, Pacific Grove, CA.
127. Allison D.B., Gorman B.S., Kucera E.M. UNICORN. A computer program for transforming data to normality. Educ Psychol Meas. 55:1995;625.
128. George V., Elston R.C. Generalized modulus power transformations. Commun Stat Theory Methods. 17:1988;2933.
129. Siegel S., Castellan N.J. Jr. Nonparametric statistics. 2nd ed :1988;McGraw-Hill, New York.
130. Allison D.B., Gorman B.S., Primavera L.H. The most common questions asked of statistical consultants our favorite responses and recommended readings . Genet Social Gen Psychol Monogr. 119:1993;153.
131. Puri M.L., Sen P.K. A class of rank order tests for a general linear hypothesis. Ann Math Stat. 40:1969;1325.
132. Berk RA. A primer on robust regression. In: Fox J, Long JS, eds. Methods of data analysis. Newbury Park, CA: Sage, 1990:292.
133. Little R.J.A., Rubin D.B. Statistical analysis with missing data. 1987;John Wiley & Sons, New York.
134. Neter J., Wasserman W., Kutner M.H. Applied linear statistical models. 3rd ed :1990;Irwin, Boston.
135. Bailar J.C., Mosteller F. Guidelines for statistical reporting in articles for medical journals. Ann Intern Med. 108:1988;266.
136. Hochberg Y., Tamhane A.C. Multiple comparison procedures. 1987;John Wiley & Sons, New York.
137. Hwang S.J., Beaty T.H., Liang K. Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am J Epidermiol. 140:1994;1029.